March saw the launch of a major contract development and manufacturing company, DPx Holdings, B.V., a merger between Royal DSM’s pharmaceutical businesses and Patheon that combines their assets in API, biologics, sterile, liquid filling and lyophilization, as well as finished dosage form manufacturing. Merging two corporate cultures is always a challenge, but the new company has been moving forward with several projects that reflect its new capabilities, and enhanced focus on the customer. Las...